Emerging roles of protein O-GlcNAcylation in cardiovascular diseases: Insights and novel therapeutic targets.
Pharmacol Res
; 165: 105467, 2021 03.
Article
em En
| MEDLINE
| ID: mdl-33515704
Palavras-chave
(R)-N-(Furan-2-ylmethyl)-2-(2-methoxyphenyl)-2-(2-oxo-1,2-dihydroquinoline-6-sulfonamido)-N-(thiophen-2-ylmethyl)acetamide [OSMI-1] (PubChem CID: 118634407); 2-(2-Amino-3-methoxyphenyl)-4H-chromen-4-one [PD98059] (PubChem CID: 4713); 5H-Pyrano[3,2-d]thiazole-6,7-diol, 2-(ethylamino)-3a,6,7,7a-tetrahydro-5-(hydroxymethyl)-(3aR,5R,6S,7R,7aR) [Thiamet-G] (PubChem CID: 1355663540); 6-Diazo-5-oxo-l-norleucine [DON] (PubChem CID: 9087); Alloxan (PubChem CID: 5781); Azaserine (PubChem CID: 460129); BADGP, Benzyl-2-acetamido-2-deoxy-α-d-galactopyranoside [BADGP] (PubChem CID: 561184); Cardiovascular disease; Methoxybenzene-sulfonamide [KN-93] (PubChem CID: 5312122); N-[(5S,6R,7R,8R)-6,7-Dihydroxy-5-(hydroxymethyl)-2-(2-phenylethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-8-yl]-2-methylpropanamide [GlcNAcstatin] (PubChem CID: 122173013); O-(2-Acetamido-2-deoxy-d-glucopyranosyliden)amino-N-phenylcarbamate [PUGNAc] (PubChem CID: 9576811); O-GlcNAc transferase; O-GlcNAcase; Protein O-GlcNAcylation; Streptozotocin (PubCHem CID: 7067772)
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Fármacos Cardiovasculares
/
Doenças Cardiovasculares
/
Processamento de Proteína Pós-Traducional
/
Sistemas de Liberação de Medicamentos
/
Inibidores Enzimáticos
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article